HAEMONETICS CORP — Director's Dealing 2015

Aug 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-08-17

Reporting Person: CONCANNON BRIAN (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-17	Common Stock	M	6569.0	$27.685	Acquired	153609	Direct
2015-08-17	Common Stock	S	6569.0	$39.2783	Disposed	147040	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-17	Non-Qualified Stock Option (right to buy)	$27.685	M	6569.0	Disposed	2016-04-02	Common Stock (6569)	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan.

F2: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.